Ipratropium bromide metered solution inhalation - Sheffield
Alternative Names: Ipratropium bromide MSI; MSI-ipratropium bromide; SCH 1000 metered solution inhalation - SheffieldLatest Information Update: 24 Oct 2021
At a glance
- Originator Sheffield Pharmaceuticals
- Class Antiasthmatics; Antibronchitics; Atropine derivatives; Bronchodilators; Small molecules
- Mechanism of Action Muscarinic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease
Most Recent Events
- 17 Jun 2003 Sheffield Pharmaceuticals has filed for protection under Chapter 7 bankruptcy laws
- 17 Jun 2003 Discontinued - Phase-II for Chronic obstructive pulmonary disease in Belgium (Inhalation)
- 17 Jun 2003 Discontinued - Phase-II for Chronic obstructive pulmonary disease in USA (Inhalation)